[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oral Cancer Diagnosis Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: GB1E8430B939EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Oral Cancer Diagnosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Cancer Diagnosis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • GE Healthcare
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Hitachi Ltd
  • PeriRx, LLC
  • Canon Medical Systems Corporation
  • Vigilant Biosciences, Inc.
  • QIAGEN
  • Koninklijke Philips NV
Market segment by Type, the product can be split into
  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Ultrasonography
  • Biopsy
  • X-Ray
  • Endoscopy
  • Fluorescence Imaging
  • Others
Market segment by Application, split into
  • Hospitals and Clinics
  • Research and Academic Institutes
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Oral Cancer Diagnosis status, future forecast, growth opportunity, key market and key players.
  • To present the Oral Cancer Diagnosis development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Oral Cancer Diagnosis are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Cancer Diagnosis Revenue
1.4 Market Analysis by Type
  1.4.1 Global Oral Cancer Diagnosis Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Computed Tomography (CT) Scan
  1.4.3 Magnetic Resonance Imaging (MRI)
  1.4.4 Positron Emission Tomography (PET)
  1.4.5 Ultrasonography
  1.4.6 Biopsy
  1.4.7 X-Ray
  1.4.8 Endoscopy
  1.4.9 Fluorescence Imaging
  1.4.10 Others
1.5 Market by Application
  1.5.1 Global Oral Cancer Diagnosis Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Research and Academic Institutes
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Oral Cancer Diagnosis Industry Impact
  1.6.1 How the Covid-19 is Affecting the Oral Cancer Diagnosis Industry
    1.6.1.1 Oral Cancer Diagnosis Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Oral Cancer Diagnosis Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Oral Cancer Diagnosis Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Oral Cancer Diagnosis Market Perspective (2015-2026)
2.2 Oral Cancer Diagnosis Growth Trends by Regions
  2.2.1 Oral Cancer Diagnosis Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Oral Cancer Diagnosis Historic Market Share by Regions (2015-2020)
  2.2.3 Oral Cancer Diagnosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Oral Cancer Diagnosis Market Growth Strategy
  2.3.6 Primary Interviews with Key Oral Cancer Diagnosis Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oral Cancer Diagnosis Players by Market Size
  3.1.1 Global Top Oral Cancer Diagnosis Players by Revenue (2015-2020)
  3.1.2 Global Oral Cancer Diagnosis Revenue Market Share by Players (2015-2020)
  3.1.3 Global Oral Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oral Cancer Diagnosis Market Concentration Ratio
  3.2.1 Global Oral Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Oral Cancer Diagnosis Revenue in 2019
3.3 Oral Cancer Diagnosis Key Players Head office and Area Served
3.4 Key Players Oral Cancer Diagnosis Product Solution and Service
3.5 Date of Enter into Oral Cancer Diagnosis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Oral Cancer Diagnosis Historic Market Size by Type (2015-2020)
4.2 Global Oral Cancer Diagnosis Forecasted Market Size by Type (2021-2026)

5 ORAL CANCER DIAGNOSIS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Oral Cancer Diagnosis Market Size by Application (2015-2020)
5.2 Global Oral Cancer Diagnosis Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Oral Cancer Diagnosis Market Size (2015-2020)
6.2 Oral Cancer Diagnosis Key Players in North America (2019-2020)
6.3 North America Oral Cancer Diagnosis Market Size by Type (2015-2020)
6.4 North America Oral Cancer Diagnosis Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Oral Cancer Diagnosis Market Size (2015-2020)
7.2 Oral Cancer Diagnosis Key Players in Europe (2019-2020)
7.3 Europe Oral Cancer Diagnosis Market Size by Type (2015-2020)
7.4 Europe Oral Cancer Diagnosis Market Size by Application (2015-2020)

8 CHINA

8.1 China Oral Cancer Diagnosis Market Size (2015-2020)
8.2 Oral Cancer Diagnosis Key Players in China (2019-2020)
8.3 China Oral Cancer Diagnosis Market Size by Type (2015-2020)
8.4 China Oral Cancer Diagnosis Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Oral Cancer Diagnosis Market Size (2015-2020)
9.2 Oral Cancer Diagnosis Key Players in Japan (2019-2020)
9.3 Japan Oral Cancer Diagnosis Market Size by Type (2015-2020)
9.4 Japan Oral Cancer Diagnosis Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Oral Cancer Diagnosis Market Size (2015-2020)
10.2 Oral Cancer Diagnosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oral Cancer Diagnosis Market Size by Type (2015-2020)
10.4 Southeast Asia Oral Cancer Diagnosis Market Size by Application (2015-2020)

11 INDIA

11.1 India Oral Cancer Diagnosis Market Size (2015-2020)
11.2 Oral Cancer Diagnosis Key Players in India (2019-2020)
11.3 India Oral Cancer Diagnosis Market Size by Type (2015-2020)
11.4 India Oral Cancer Diagnosis Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Oral Cancer Diagnosis Market Size (2015-2020)
12.2 Oral Cancer Diagnosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Oral Cancer Diagnosis Market Size by Type (2015-2020)
12.4 Central & South America Oral Cancer Diagnosis Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GE Healthcare
  13.1.1 GE Healthcare Company Details
  13.1.2 GE Healthcare Business Overview and Its Total Revenue
  13.1.3 GE Healthcare Oral Cancer Diagnosis Introduction
  13.1.4 GE Healthcare Revenue in Oral Cancer Diagnosis Business (2015-2020))
  13.1.5 GE Healthcare Recent Development
13.2 F. Hoffmann-La Roche Ltd
  13.2.1 F. Hoffmann-La Roche Ltd Company Details
  13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.2.3 F. Hoffmann-La Roche Ltd Oral Cancer Diagnosis Introduction
  13.2.4 F. Hoffmann-La Roche Ltd Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Thermo Fisher Scientific Inc.
  13.3.1 Thermo Fisher Scientific Inc. Company Details
  13.3.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  13.3.3 Thermo Fisher Scientific Inc. Oral Cancer Diagnosis Introduction
  13.3.4 Thermo Fisher Scientific Inc. Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.3.5 Thermo Fisher Scientific Inc. Recent Development
13.4 Siemens Healthineers
  13.4.1 Siemens Healthineers Company Details
  13.4.2 Siemens Healthineers Business Overview and Its Total Revenue
  13.4.3 Siemens Healthineers Oral Cancer Diagnosis Introduction
  13.4.4 Siemens Healthineers Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.4.5 Siemens Healthineers Recent Development
13.5 Hitachi Ltd
  13.5.1 Hitachi Ltd Company Details
  13.5.2 Hitachi Ltd Business Overview and Its Total Revenue
  13.5.3 Hitachi Ltd Oral Cancer Diagnosis Introduction
  13.5.4 Hitachi Ltd Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.5.5 Hitachi Ltd Recent Development
13.6 PeriRx, LLC
  13.6.1 PeriRx, LLC Company Details
  13.6.2 PeriRx, LLC Business Overview and Its Total Revenue
  13.6.3 PeriRx, LLC Oral Cancer Diagnosis Introduction
  13.6.4 PeriRx, LLC Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.6.5 PeriRx, LLC Recent Development
13.7 Canon Medical Systems Corporation
  13.7.1 Canon Medical Systems Corporation Company Details
  13.7.2 Canon Medical Systems Corporation Business Overview and Its Total Revenue
  13.7.3 Canon Medical Systems Corporation Oral Cancer Diagnosis Introduction
  13.7.4 Canon Medical Systems Corporation Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.7.5 Canon Medical Systems Corporation Recent Development
13.8 Vigilant Biosciences, Inc.
  13.8.1 Vigilant Biosciences, Inc. Company Details
  13.8.2 Vigilant Biosciences, Inc. Business Overview and Its Total Revenue
  13.8.3 Vigilant Biosciences, Inc. Oral Cancer Diagnosis Introduction
  13.8.4 Vigilant Biosciences, Inc. Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.8.5 Vigilant Biosciences, Inc. Recent Development
13.9 QIAGEN
  13.9.1 QIAGEN Company Details
  13.9.2 QIAGEN Business Overview and Its Total Revenue
  13.9.3 QIAGEN Oral Cancer Diagnosis Introduction
  13.9.4 QIAGEN Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.9.5 QIAGEN Recent Development
13.10 Koninklijke Philips NV
  13.10.1 Koninklijke Philips NV Company Details
  13.10.2 Koninklijke Philips NV Business Overview and Its Total Revenue
  13.10.3 Koninklijke Philips NV Oral Cancer Diagnosis Introduction
  13.10.4 Koninklijke Philips NV Revenue in Oral Cancer Diagnosis Business (2015-2020)
  13.10.5 Koninklijke Philips NV Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Oral Cancer Diagnosis Key Market Segments
Table 2. Key Players Covered: Ranking by Oral Cancer Diagnosis Revenue
Table 3. Ranking of Global Top Oral Cancer Diagnosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oral Cancer Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Computed Tomography (CT) Scan
Table 6. Key Players of Magnetic Resonance Imaging (MRI)
Table 7. Key Players of Positron Emission Tomography (PET)
Table 8. Key Players of Ultrasonography
Table 9. Key Players of Biopsy
Table 10. Key Players of X-Ray
Table 11. Key Players of Endoscopy
Table 12. Key Players of Fluorescence Imaging
Table 13. Key Players of Others
Table 14. COVID-19 Impact Global Market: (Four Oral Cancer Diagnosis Market Size Forecast Scenarios)
Table 15. Opportunities and Trends for Oral Cancer Diagnosis Players in the COVID-19 Landscape
Table 16. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 17. Key Regions/Countries Measures against Covid-19 Impact
Table 18. Proposal for Oral Cancer Diagnosis Players to Combat Covid-19 Impact
Table 19. Global Oral Cancer Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 20. Global Oral Cancer Diagnosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 21. Global Oral Cancer Diagnosis Market Size by Regions (2015-2020) (US$ Million)
Table 22. Global Oral Cancer Diagnosis Market Share by Regions (2015-2020)
Table 23. Global Oral Cancer Diagnosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 24. Global Oral Cancer Diagnosis Market Share by Regions (2021-2026)
Table 25. Market Top Trends
Table 26. Key Drivers: Impact Analysis
Table 27. Key Challenges
Table 28. Oral Cancer Diagnosis Market Growth Strategy
Table 29. Main Points Interviewed from Key Oral Cancer Diagnosis Players
Table 30. Global Oral Cancer Diagnosis Revenue by Players (2015-2020) (Million US$)
Table 31. Global Oral Cancer Diagnosis Market Share by Players (2015-2020)
Table 32. Global Top Oral Cancer Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Diagnosis as of 2019)
Table 33. Global Oral Cancer Diagnosis by Players Market Concentration Ratio (CR5 and HHI)
Table 34. Key Players Headquarters and Area Served
Table 35. Key Players Oral Cancer Diagnosis Product Solution and Service
Table 36. Date of Enter into Oral Cancer Diagnosis Market
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 39. Global Oral Cancer Diagnosis Market Size Share by Type (2015-2020)
Table 40. Global Oral Cancer Diagnosis Revenue Market Share by Type (2021-2026)
Table 41. Global Oral Cancer Diagnosis Market Size Share by Application (2015-2020)
Table 42. Global Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 43. Global Oral Cancer Diagnosis Market Size Share by Application (2021-2026)
Table 44. North America Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 45. North America Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 46. North America Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 47. North America Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 48. North America Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 49. North America Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 50. Europe Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 51. Europe Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 52. Europe Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 53. Europe Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 54. Europe Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 55. Europe Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 56. China Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 57. China Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 58. China Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 59. China Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 60. China Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 61. China Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 62. Japan Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 63. Japan Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 64. Japan Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 65. Japan Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 66. Japan Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 67. Japan Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 68. Southeast Asia Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 69. Southeast Asia Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 70. Southeast Asia Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 71. Southeast Asia Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 72. Southeast Asia Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 73. Southeast Asia Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 74. India Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 75. India Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 76. India Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 77. India Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 78. India Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 79. India Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 80. Central & South America Key Players Oral Cancer Diagnosis Revenue (2019-2020) (Million US$)
Table 81. Central & South America Key Players Oral Cancer Diagnosis Market Share (2019-2020)
Table 82. Central & South America Oral Cancer Diagnosis Market Size by Type (2015-2020) (Million US$)
Table 83. Central & South America Oral Cancer Diagnosis Market Share by Type (2015-2020)
Table 84. Central & South America Oral Cancer Diagnosis Market Size by Application (2015-2020) (Million US$)
Table 85. Central & South America Oral Cancer Diagnosis Market Share by Application (2015-2020)
Table 86. GE Healthcare Company Details
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Product
Table 89. GE Healthcare Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 90. GE Healthcare Recent Development
Table 91. F. Hoffmann-La Roche Ltd Company Details
Table 92. F. Hoffmann-La Roche Ltd Business Overview
Table 93. F. Hoffmann-La Roche Ltd Product
Table 94. F. Hoffmann-La Roche Ltd Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 95. F. Hoffmann-La Roche Ltd Recent Development
Table 96. Thermo Fisher Scientific Inc. Company Details
Table 97. Thermo Fisher Scientific Inc. Business Overview
Table 98. Thermo Fisher Scientific Inc. Product
Table 99. Thermo Fisher Scientific Inc. Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 100. Thermo Fisher Scientific Inc. Recent Development
Table 101. Siemens Healthineers Company Details
Table 102. Siemens Healthineers Business Overview
Table 103. Siemens Healthineers Product
Table 104. Siemens Healthineers Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 105. Siemens Healthineers Recent Development
Table 106. Hitachi Ltd Company Details
Table 107. Hitachi Ltd Business Overview
Table 108. Hitachi Ltd Product
Table 109. Hitachi Ltd Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 110. Hitachi Ltd Recent Development
Table 111. PeriRx, LLC Company Details
Table 112. PeriRx, LLC Business Overview
Table 113. PeriRx, LLC Product
Table 114. PeriRx, LLC Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 115. PeriRx, LLC Recent Development
Table 116. Canon Medical Systems Corporation Company Details
Table 117. Canon Medical Systems Corporation Business Overview
Table 118. Canon Medical Systems Corporation Product
Table 119. Canon Medical Systems Corporation Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 120. Canon Medical Systems Corporation Recent Development
Table 121. Vigilant Biosciences, Inc. Business Overview
Table 122. Vigilant Biosciences, Inc. Product
Table 123. Vigilant Biosciences, Inc. Company Details
Table 124. Vigilant Biosciences, Inc. Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 125. Vigilant Biosciences, Inc. Recent Development
Table 126. QIAGEN Company Details
Table 127. QIAGEN Business Overview
Table 128. QIAGEN Product
Table 129. QIAGEN Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 130. QIAGEN Recent Development
Table 131. Koninklijke Philips NV Company Details
Table 132. Koninklijke Philips NV Business Overview
Table 133. Koninklijke Philips NV Product
Table 134. Koninklijke Philips NV Revenue in Oral Cancer Diagnosis Business (2015-2020) (Million US$)
Table 135. Koninklijke Philips NV Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Oral Cancer Diagnosis Market Share by Type: 2020 VS 2026
Figure 2. Computed Tomography (CT) Scan Features
Figure 3. Magnetic Resonance Imaging (MRI) Features
Figure 4. Positron Emission Tomography (PET) Features
Figure 5. Ultrasonography Features
Figure 6. Biopsy Features
Figure 7. X-Ray Features
Figure 8. Endoscopy Features
Figure 9. Fluorescence Imaging Features
Figure 10. Others Features
Figure 11. Global Oral Cancer Diagnosis Market Share by Application: 2020 VS 2026
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Research and Academic Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Oral Cancer Diagnosis Report Years Considered
Figure 16. Global Oral Cancer Diagnosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Oral Cancer Diagnosis Market Share by Regions: 2020 VS 2026
Figure 18. Global Oral Cancer Diagnosis Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Oral Cancer Diagnosis Market Share by Players in 2019
Figure 21. Global Top Oral Cancer Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Diagnosis as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Oral Cancer Diagnosis Revenue in 2019
Figure 23. North America Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Oral Cancer Diagnosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GE Healthcare Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 32. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 34. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 36. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Siemens Healthineers Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 38. Hitachi Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Hitachi Ltd Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 40. PeriRx, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. PeriRx, LLC Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 42. Canon Medical Systems Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Canon Medical Systems Corporation Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 44. Vigilant Biosciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Vigilant Biosciences, Inc. Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 46. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. QIAGEN Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 48. Koninklijke Philips NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Koninklijke Philips NV Revenue Growth Rate in Oral Cancer Diagnosis Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed


More Publications